Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer

Fig. 1

The effects of TAK-960 on CRC cell lines in vitro. Fifty-five CRC cell lines were exposed to increasing concentrations of TAK-960. Proliferation was assessed by CyQuant Assay. IC50 +/- SEM was calculated for all cell lines and ranged from < 0.001 μM to > 0.75 μM. Mutant genes are shown by colored boxes. There is no significant correlation between sensitivity and the genetic mutations depicted. N≥3

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us